Barrington Research Increases Henry Schein (NASDAQ:HSIC) Price Target to $90.00

Henry Schein (NASDAQ:HSIC) had its target price increased by investment analysts at Barrington Research from $82.00 to $90.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Barrington Research’s price objective would suggest a potential upside of 12.68% from the stock’s current price.

A number of other brokerages have also recently issued reports on HSIC. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Finally, Jefferies Financial Group increased their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $80.10.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $79.87 on Thursday. The business has a 50 day moving average price of $73.19 and a 200 day moving average price of $71.27. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a market cap of $9.96 billion, a price-to-earnings ratio of 32.87, a PEG ratio of 2.04 and a beta of 0.89. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 EPS. Research analysts predict that Henry Schein will post 4.78 earnings per share for the current year.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. ING Groep NV bought a new position in shares of Henry Schein in the 3rd quarter worth $63,226,000. Holocene Advisors LP bought a new position in shares of Henry Schein in the 3rd quarter worth $58,319,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Henry Schein in the 3rd quarter worth $43,740,000. Southpoint Capital Advisors LP boosted its position in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Finally, Bank of Montreal Can boosted its position in shares of Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock worth $52,095,000 after purchasing an additional 558,689 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.